Synfacts 2023; 19(04): 0416
DOI: 10.1055/s-0042-1751839
Innovative Drug Discovery and Development

Synthesis of Anesthetic Ketamine

Rezensent(en):
Dirk Trauner
,
Tongil Ko
Stevens CL, *, Klundt IL, Munk ME, Pillai MD. Wayne State University, Detroit, USA
Amino Ketone Rearrangements. IV. Thermal Rearrangements of α-Amino Methyl Ketones.

J. Org. Chem. 1965;
30: 2967-2972
DOI: 10.1021/jo01020a019
 

Significance

Ketamine is an anesthetic drug used both in human and veterinary medicine. It acts primarily as a noncompetitive antagonist of the NMDA receptor, but also shows an activating effect on AMPA receptors. Besides its use as a sedative or pain management drug, ketamine has been shown to be a potent short-acting antidepressant. It induces effects similar to phencyclidine (PCP) with reduced behavioral toxicity.


#

Comment

The key methodology for the synthesis of ketamine is a thermal rearrangement of α-hydroxy imines to α-amino ketones. This was developed by Stevens and co-workers, who also reported on a series of analogs in a patent (US patent 3254124), which included ketamine. Although synthesized as a racemic mixture, the two enantiomers have remarkably different pharmacologies, with (S)-ketamine being a more potent anesthetic and (R)-ketamine being a more potent antidepressant.


#
#

Publikationsverlauf

Artikel online veröffentlicht:
17. März 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany